日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered NKG2C (+) NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome

经基因工程改造的NKG2C(+) NK样T细胞表现出优异的抗肿瘤疗效,同时还能减轻细胞因子释放综合征。

Lupo, Kyle B; Panjwani, M Kazim; Shahid, Sanam; Sottile, Rosa; Lawry, Clara; Kolk, Gabryelle; Kontopolous, Theodota; Daniyan, Anthony F; Chandran, Smita S; Klebanoff, Christopher A; Hsu, Katharine C